Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Methylphenidate for Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/435697/all/Methylphenidate_for_children_and_adolescents_with_attention_deficit_hyperactivity_disorder__ADHD_.
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD). Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435697/all/Methylphenidate_for_children_and_adolescents_with_attention_deficit_hyperactivity_disorder__ADHD_. Accessed February 13, 2025.
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD). (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435697/all/Methylphenidate_for_children_and_adolescents_with_attention_deficit_hyperactivity_disorder__ADHD_
Methylphenidate for Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD) [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 February 13]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/435697/all/Methylphenidate_for_children_and_adolescents_with_attention_deficit_hyperactivity_disorder__ADHD_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)
ID - 435697
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435697/all/Methylphenidate_for_children_and_adolescents_with_attention_deficit_hyperactivity_disorder__ADHD_
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -